Navigation Links
Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria
Date:2/24/2010

of Maryland School of Medicine, in a poster presentation entitled Human Adaptive Immune Response to Bacillus Anthracis.  

Valortim® is a fully human anti-toxin monoclonal antibody being developed for the prevention and treatment of inhalational anthrax.  Preclinical studies suggest that Valortim® has the potential to provide protection against anthrax infection when administered prophylactically (prior to the emergence of symptoms of anthrax infection) and also may increase survival when administered therapeutically (once symptoms become evident).

Previous data presented by Drs. Cross and Basu have shown that in addition to inhibiting anthrax toxin, Valortim® appears to augment the immune system's ability to kill anthrax bacilli by enhancing the human dendritic cell response to a challenge with anthrax spores.  These new data expand upon these observations by showing that Valortim® also enhances the human T cell response to B. anthracis. In addition to Valortim's established toxin-neutralizing function, which has been previously described, these studies indicate that it may also assist in enhancing the adaptive immune response to anthrax, which may lead to a reduction and clearance of the bacteria in the host organism.

Dr. Cross remarked, "Our latest research using human immune cells pr
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
2. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
3. Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
4. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
5. Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
6. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
7. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
8. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
9. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
10. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
11. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015  Semler Scientific, Inc. (Nasdaq: SMLR ... to healthcare insurers and physician groups, today reported financial ... "In the second quarter of 2015, ... growth of 54%, quarter over quarter revenue growth of ... base of FloChec® units of 18%," said Doug Murphy-Chutorian, ...
(Date:7/31/2015)... and SAN DIEGO , July ... parent company Eisai Co., Ltd. (Headquarters: Tokyo ... "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: San ... Helen Torley , "NASDAQ: HALO") have signed a clinical ... Halaven ® , "eribulin") in combination with Halozyme,s investigational ...
(Date:7/31/2015)... 2015  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... Hata to its board of directors. ... development is a tremendous asset to our board," said ... officer of Xencor. "Xencor faces a range of opportunities ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical ... Monday, August 1, 2011 before the opening of the U.S. ... that day at 10:00 a.m. ET to discuss results and ... be used during the call will be available on the ...
... 18, 2011 Reportlinker.com announces that ... available in its catalogue: ... BRICS (Brazil, Russia, India, China, South ... http://www.reportlinker.com/p0573105/Neurosurgical-Products-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging Neurosurgical ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011 2Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011 3Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15
(Date:7/31/2015)... ... ... New Energy Works Timberframers invites the public to join their timber frame ... 9am – 12pm. Timber frame raisings are special, celebrating both craft and ... culmination of months of effort, planning, fundraising, and dreaming takes shape. , “There’s ...
(Date:7/31/2015)... ... 2015 , ... Super-Sod wants to participate in planning new home lawns from ... the perfect fit for such a goal. Houzz is a social media site that ... dynamic site that spreads home and home garden design ideas when members share their ...
(Date:7/31/2015)... DE (PRWEB) , ... July 31, 2015 , ... ... term care client base, with the recent implementation of Microsoft Dynamics GP for ... in the industry, Intellitec is now supporting senior living communities in 16 states. ...
(Date:7/30/2015)... ... , ... Dale Sky Jones, Executive Chancellor of Oaksterdam University , the ... Expo held at the Caribe Royal All Suites Hotel and Convention Center in Orlando, ... the largest medical cannabis expo in the country and this year’s expo will be ...
(Date:7/30/2015)... ... July 30, 2015 , ... World Patent Marketing, ... an app invention that can help people during emergencies. , "The worldwide mobile ... and Creative Director of World Patent Marketing. "Currently, there are about 97,000 mobile ...
Breaking Medicine News(10 mins):Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5
... HealthDay Reporter , WEDNESDAY, Oct. 27 (HealthDay ... the vaccine that protects against bacterial meningitis, a U.S. ... the recommendation because the vaccine appears not to last ... U.S. Centers for Disease Control and Prevention,s Advisory Committee ...
... develops and spreads much more slowly than scientists have ... The finding indicates that there is a potentially broad ... "For the first time, we have a quantifiable estimate ... would be best to intervene," according to Christine Iacobuzio-Donahue, ...
... planning of care and stronger relationships with physicians are ... a study by a Queen,s University professor. , "High ... Canadian," says professor of Medicine and Epidemiology Daren Heyland, ... "But it,s not always happening. We know from international ...
... , WEDNESDAY, Oct. 27 (HealthDay News) -- With October ... offers breast cancer survivors some guidance on what they ... Karen Syrjala, director of biobehavioral sciences and co-director of ... Center in Seattle, touches upon both the lingering physical ...
... Carolina (UNC) researchers report in the November issue of ... diagnostic testing are overused in treating chronic neck pain. ... for neck pain, such as therapeutic exercise. According to ... effectiveness of therapeutic exercise in treating chronic neck pain ...
... not considered effective treatment for KRAS (a gene)-mutated metastatic ... cancer not responding to chemotherapy and a certain variation ... longer overall and progression-free survival than patients with other ... issue of JAMA . "Recent retrospective ...
Cached Medicine News:Health News:Teens Should Get Meningitis Booster Shot: CDC Panel 2Health News:Surprise finding: Pancreatic cancers progress to lethal stage slowly 2Health News:Surprise finding: Pancreatic cancers progress to lethal stage slowly 3Health News:Women Urged to Reclaim Their Life After Breast Cancer 2Health News:Narcotics and diagnostics overused in treatment of chronic neck pain 2Health News:Colorectal cancer patients with gene mutation show better response to cancer agent 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: